May 4, 2020 / 1:17 PM / 22 days ago

BRIEF-Generex Biotechnology Initiates Peptide Manufacturing For Ii-Key- SARS-CoV-2 Peptide Vaccine

May 4 (Reuters) - Generex Biotechnology Corp:

* GENEREX BIOTECHNOLOGY INITIATES PEPTIDE MANUFACTURING FOR II-KEY- SARS-COV-2 PEPTIDE VACCINE AGAINST THE COVID-19 PANDEMIC

* GENEREX BIOTECHNOLOGY - SUBMITTED PROPOSAL TO BARDA FOR START-TO-FINISH FUNDING TO DEVELOP VACCINE AGAINST SARS-COV-2 CORONAVIRUS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below